Please note that masks are still required in all Blue Ridge Cancer Care offices regardless of vaccination status.
Learn more about this and other current Covid-19 policies.

Research Team

Director, Research Operations

Manages the Clinical Research Program, Operations, financials, and Research Staff across the five locations. Collaborates with Sponsors, Clinical Research Organizations (CROs), and the US Oncology Network to facilitate clinical trial opportunities while overseeing all contract and budget negotiations.

Natasha Holt, CCRP

Natasha Holt, CCRP

Clinical Research Supervisor

Collaborates in the development of research accountability standards, metrics, and quality for the Research Staff. Provides administrative support to the Clinical Research Manager and leadership team.

Andi Pollard, CCRC

Andi Pollard, CCRC

Budget Analyst

Responsible for managing the financials for Phase I-IV clinical trials working closely with US Oncology and Sponsors.

Dana Selvia, CCRP

Dana Selvia, CCRP

Clinical Research Nurse – Phase I

Responsible for enrolling patients onto Phase I clinical trials, administering all medications to patients on Phase I trials, and providing/coordinating patient care while protecting the integrity of the clinical trial.

Holland Ragland, RN

Holland Ragland, RN

Clinical Research Coordinators/Nurses

Responsible for enrolling patients on Phase II-IV clinical trials and providing/coordinating patient care while protecting the integrity of the clinical trial.

Monica Sarp

Monica Sarp

Kelly Wade

Kelly Wade

Katherine Stauffer

Katherine Stauffer

Caitlin Aslanidis

Caitlin Aslanidis

Data Coordinators

Responsible for extrapolating data from source records for all clinical trials and submission to Sponsors and/or Clinical Research Organizations (CROs)

Kim Young

Kim Young

Keisha Smith

Keisha Smith

Clinical Research Assistant

Responsible for managing all drug and lab kits for the Phase I-IV clinical trials

Billie Prillaman

Billie Prillaman

Regulatory Coordinators

Responsible for managing the regulatory for Phase I-IV clinical trials working closely with Institutional Review Boards (IRBs)

Taylor Daly

Taylor Daly